↓ Skip to main content

The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells

Overview of attention for article published in BMC Cancer, December 2015
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
57 Mendeley